Diagnostics

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. PatienceTriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

TriSalus Life Sciences Announces Chief Financial Officer Transition With Appointment of David B. Patience

David Patience, an accomplished healthcare CFO with deep experience in the life sciences sector, appointed as CFO effective July 1,…

4 weeks ago
Spectral AI Announces Appointment of Stanley Micek as Chief Operating OfficerSpectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

Spectral AI Announces Appointment of Stanley Micek as Chief Operating Officer

DALLAS, May 30, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence…

4 weeks ago
EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategyEssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy

EssilorLuxottica to acquire Optegra clinics, another leap forward in its med-tech strategy

EssilorLuxottica to acquire Optegra clinics,another leap forward in its med-tech strategy Acquisition of leading ophthalmology platform from MidEuropa will advance…

4 weeks ago
Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCOLeading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO

Leading with Light: MUSE Microscopy Illuminates the Next Era of Oncology at ASCO

IRVINE, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, (the “Company”, “we”, “our”) a leader in slide-free, tissue-to-digital™ pathology…

4 weeks ago
New Data at ASCO 2025 Affirms DecisionDx®-Melanoma’s Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival OutcomesNew Data at ASCO 2025 Affirms DecisionDx®-Melanoma’s Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

New Data at ASCO 2025 Affirms DecisionDx®-Melanoma’s Ability to Improve Upon Staging-Based Risk Stratification and Predict Survival Outcomes

Study results show that DecisionDx-Melanoma was associated with a 32% reduction in mortality risk compared to untested patientsFRIENDSWOOD, Texas, May…

4 weeks ago
Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision MedicineDanaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

Danaher Announces Diagnostic Development and Commercialization Partnership to Scale Precision Medicine

Danaher has entered a partnership with AstraZeneca to scale precision medicine, including developing the next generation of AI-powered diagnosticsThis partnership…

4 weeks ago
MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Gold Nanoparticles Quadrant Report 2025MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Gold Nanoparticles Quadrant Report 2025

MarketsandMarkets’ 360Quadrants Recognizes Top Startups and SMEs in the Gold Nanoparticles Quadrant Report 2025

DELRAY BEACH, Fla., May 29, 2025 /PRNewswire/ -- 360Quadrants has released its latest Gold Nanoparticles Startups/SMEs Companies Assessment, 2025, recognizing key…

4 weeks ago
NLP in Healthcare & Life Sciences Market worth $16.01 billion by 2030- Exclusive Report by MarketsandMarkets™NLP in Healthcare & Life Sciences Market worth $16.01 billion by 2030- Exclusive Report by MarketsandMarkets™

NLP in Healthcare & Life Sciences Market worth $16.01 billion by 2030- Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., May 29, 2025 /PRNewswire/ -- The NLP in Healthcare & Life Sciences Market is expected to significantly increase…

4 weeks ago